OSTEO-ARTICULAR CLINICAL EVALUATION RESULTS
DendrisKIT OA : Clinical study – Dendris / INOVIE group
February to November 2022
360 samples tested (99 patients)
Aim : Analyze the concordance and performance of DendrisKIT OA against conventional bacteriological methods.
Sampling : Dendris’ technology was carried out using residues of samples from orthopedic surgery departments recovered from the INOVIE-CBM Muret laboratory (31).
Hypothesis : Techniques are considered to be concordant if they have at least one bacterium in common.
The results are 74% concordant between the laboratory method and the DendrisKIT OA. In addition, the kit found a higher proportion of Staphylococcus spp (19 samples) and Cutibacterium acnes (13 samples) verified at 90% by sequencing.
DERMATOPHYTES STUDY RESULTS
DendrisKIT DP : Preliminary study – Dendris / INOVIE group v1.0
June to October 2022
119 samples tested
Aim : Analyze the concordance and performance of DendrisKIT DP against conventional microbiological methods.
Sampling : Dendris’ technology was carried out from different types of samples collected from the CBM Muret (31) and Labosud Montpellier (34) laboratories: residual samples and swabs from the infected area by surface sampling.
Hypothesis : Techniques are considered to be concordant if they have at least one pathogen in common.